IPO · ISPC
iSpecimen Inc.
iSpecimen Inc. (ISPC) priced its initial public offering on Jun 21, 2021 at $8.00 per share, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $51.9M. ThinkEquity was lead-left underwriter. Ellenoff Grossman & Schole advised the company and Blank Rome advised the underwriters.
iSpecimen Inc. operates a global marketplace platform that connects life science researchers to subjects, specimens and associated data. Its stated mission is to accelerate life science research and development, and it aims to create a marketplace of patients, biospecimens and data for research.
- Status
- IPO
- Ticker
- ISPC
- Exchange
- Nasdaq Capital Market
- Priced
- Jun 21, 2021
- IPO price
- $8.00
- Market cap at IPO price
- $51.9M
- First filed
- Nov 19, 2020
- Underwriters
- ThinkEquity
- Company counsel
- Ellenoff Grossman & Schole
- Underwriters' counsel
- Blank Rome
- Sector
- Biotech & pharma
- Country / state
- MA
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Nov 19, 2020
- Latest amendment May 27, 2021
- Final prospectus (424B4) Jun 21, 2021
- All filings on EDGAR CIK 1558569
Other Biotech & pharma IPOs in 2021
- Miromatrix Medical Inc.MIRO · Jun 24, 2021 · $43.2M
- Atai Beckley N.V.ATAI · Jun 21, 2021 · $225M
- Ambrx Biopharma Cayman, Inc.AMAM · Jun 21, 2021 · $126M
- Century Therapeutics, Inc.IPSC · Jun 21, 2021
- Cyteir Therapeutics, Inc.CYT · Jun 21, 2021 · $133.2M
- Lyell Immunopharma, Inc.LYEL · Jun 21, 2021 · $425M